Trial
NCT03988231
Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Venous Thromboembolism
Intervention
Receipt of enoxaparin
Why stopped
Funding was not received.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-08